NM_005956.4:c.878G>A

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_005956.4(MTHFD1):​c.878G>A​(p.Arg293His) variant causes a missense change. The variant allele was found at a frequency of 0.00265 in 1,612,896 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0024 ( 7 hom., cov: 32)
Exomes 𝑓: 0.0027 ( 8 hom. )

Consequence

MTHFD1
NM_005956.4 missense

Scores

1
5
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3O:1

Conservation

PhyloP100: 3.74
Variant links:
Genes affected
MTHFD1 (HGNC:7432): (methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1) This gene encodes a protein that possesses three distinct enzymatic activities, 5,10-methylenetetrahydrofolate dehydrogenase, 5,10-methenyltetrahydrofolate cyclohydrolase and 10-formyltetrahydrofolate synthetase. Each of these activities catalyzes one of three sequential reactions in the interconversion of 1-carbon derivatives of tetrahydrofolate, which are substrates for methionine, thymidylate, and de novo purine syntheses. The trifunctional enzymatic activities are conferred by two major domains, an aminoterminal portion containing the dehydrogenase and cyclohydrolase activities and a larger synthetase domain. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009117931).
BP6
Variant 14-64425752-G-A is Benign according to our data. Variant chr14-64425752-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 13632.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Benign=1, Uncertain_significance=1}.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0024 (365/152242) while in subpopulation NFE AF= 0.00319 (217/68014). AF 95% confidence interval is 0.00284. There are 7 homozygotes in gnomad4. There are 181 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 7 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MTHFD1NM_005956.4 linkc.878G>A p.Arg293His missense_variant Exon 10 of 28 ENST00000652337.1 NP_005947.3 P11586
MTHFD1NM_001364837.1 linkc.878G>A p.Arg293His missense_variant Exon 10 of 27 NP_001351766.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MTHFD1ENST00000652337.1 linkc.878G>A p.Arg293His missense_variant Exon 10 of 28 NM_005956.4 ENSP00000498336.1 P11586

Frequencies

GnomAD3 genomes
AF:
0.00240
AC:
365
AN:
152124
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000507
Gnomad AMI
AF:
0.0866
Gnomad AMR
AF:
0.00118
Gnomad ASJ
AF:
0.00374
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000830
Gnomad FIN
AF:
0.000848
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00319
Gnomad OTH
AF:
0.00191
GnomAD3 exomes
AF:
0.00167
AC:
421
AN:
251428
Hom.:
1
AF XY:
0.00166
AC XY:
226
AN XY:
135900
show subpopulations
Gnomad AFR exome
AF:
0.000493
Gnomad AMR exome
AF:
0.000405
Gnomad ASJ exome
AF:
0.00367
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000359
Gnomad FIN exome
AF:
0.00120
Gnomad NFE exome
AF:
0.00273
Gnomad OTH exome
AF:
0.00228
GnomAD4 exome
AF:
0.00268
AC:
3914
AN:
1460654
Hom.:
8
Cov.:
31
AF XY:
0.00261
AC XY:
1895
AN XY:
726644
show subpopulations
Gnomad4 AFR exome
AF:
0.000658
Gnomad4 AMR exome
AF:
0.000581
Gnomad4 ASJ exome
AF:
0.00237
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000464
Gnomad4 FIN exome
AF:
0.000899
Gnomad4 NFE exome
AF:
0.00314
Gnomad4 OTH exome
AF:
0.00377
GnomAD4 genome
AF:
0.00240
AC:
365
AN:
152242
Hom.:
7
Cov.:
32
AF XY:
0.00243
AC XY:
181
AN XY:
74432
show subpopulations
Gnomad4 AFR
AF:
0.000505
Gnomad4 AMR
AF:
0.00118
Gnomad4 ASJ
AF:
0.00374
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000831
Gnomad4 FIN
AF:
0.000848
Gnomad4 NFE
AF:
0.00319
Gnomad4 OTH
AF:
0.00189
Alfa
AF:
0.00294
Hom.:
3
Bravo
AF:
0.00260
TwinsUK
AF:
0.00351
AC:
13
ALSPAC
AF:
0.00337
AC:
13
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.00314
AC:
27
ExAC
AF:
0.00154
AC:
187
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00311
EpiControl
AF:
0.00237

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Oct 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

MTHFD1: BP4 -

Jan 22, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia Uncertain:1
Aug 16, 2021
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

MTHFD1 NM_005956.3 exon 10 p.Arg293His (c.878G>A): This variant has been reported in the literature in 1 individual in association with neural tube defects, segregating with disease in 1 affected family member (Hol 1998 PMID:9611072). This variant is present in 0.3% (217/68022) of European alleles and in 7 homozygotes in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/14-64425752-G-A?dataset=gnomad_r3). This variant is present in ClinVar (Variation ID: 13632). This variant amino acid (Histidine) is present in several species including multiple mammals, and is not well conserved among evolutionarily distant species; this suggests that this variant may not impact the protein. Additional computational prediction tools are unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -

not specified Benign:1
May 04, 2022
Mendelics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Spina bifida, folate-sensitive, susceptibility to Other:1
Feb 01, 1998
OMIM
Significance: risk factor
Review Status: no assertion criteria provided
Collection Method: literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.090
CADD
Benign
19
DANN
Uncertain
0.99
Eigen
Benign
-0.22
Eigen_PC
Benign
-0.18
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.90
.;D
M_CAP
Benign
0.034
D
MetaRNN
Benign
0.0091
T;T
MetaSVM
Benign
-0.84
T
PrimateAI
Benign
0.29
T
PROVEAN
Uncertain
-3.0
D;.
REVEL
Benign
0.24
Sift
Uncertain
0.019
D;.
Sift4G
Uncertain
0.025
D;D
Polyphen
0.040
B;.
Vest4
0.70
MVP
0.90
MPC
0.45
ClinPred
0.036
T
GERP RS
2.2

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs34181110; hg19: chr14-64892470; API